Correlation Between Bristol Myers and Cocrystal Pharma
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Cocrystal Pharma, you can compare the effects of market volatilities on Bristol Myers and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Cocrystal Pharma.
Diversification Opportunities for Bristol Myers and Cocrystal Pharma
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bristol and Cocrystal is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Bristol Myers i.e., Bristol Myers and Cocrystal Pharma go up and down completely randomly.
Pair Corralation between Bristol Myers and Cocrystal Pharma
Considering the 90-day investment horizon Bristol Myers Squibb is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Bristol Myers Squibb is 2.95 times less risky than Cocrystal Pharma. The stock trades about -0.01 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 244.00 in Cocrystal Pharma on September 4, 2024 and sell it today you would lose (37.00) from holding Cocrystal Pharma or give up 15.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 99.8% |
| Values | Daily Returns |
Bristol Myers Squibb vs. Cocrystal Pharma
Performance |
| Timeline |
| Bristol Myers Squibb |
| Cocrystal Pharma |
Bristol Myers and Cocrystal Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bristol Myers and Cocrystal Pharma
The main advantage of trading using opposite Bristol Myers and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.| Bristol Myers vs. AbbVie Inc | Bristol Myers vs. Merck Company | Bristol Myers vs. Gilead Sciences | Bristol Myers vs. Johnson Johnson |
| Cocrystal Pharma vs. RenovoRx | Cocrystal Pharma vs. Tempest Therapeutics | Cocrystal Pharma vs. Ikena Oncology | Cocrystal Pharma vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |